Breast and lung cancer patients with low levels of TTP protein have poorer prognosis

[News]

Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.

More... (http://www.news-medical.net/news/20150131/Breast-and-lung-cancer-patients-with-low-levels-of-TTP-protein-have-poorer-prognosis.aspx)